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ABSTRACT
Objective To assess the value of left ventricular (LV)
dyssynchrony, using phase analysis of nuclear
single-photon emission computed tomography (SPECT)
myocardial perfusion imaging (MPI) as independent
predictor of cardiac events.
Methods Phase analysis using Emory Cardiac Toolbox
was applied on gated rest MPI scans to assess LV
dyssynchrony in a total of 202 patients. Follow-up was
obtained in 197 patients (97.5%). Major adverse cardiac
events (MACE) (cardiac death and hospitalisation for any
cardiac reasons, including worsening of heart failure,
non-fatal myocardial infarction, unstable angina and
coronary revascularisation) were determined using the
KaplaneMeier method. Cox proportional hazard
regression was used to identify independent predictors
of cardiac events.
Results At a median follow-up of 3.261.2 years,
41 patients had at least one event, including 5 cardiac
deaths. LV dyssynchrony (n¼35) was associated with
a significantly higher incidence of MACE (p<0.001) and
proved to be an independent predictor of cardiac events.
Conclusion LV dyssynchrony assessed by phase
analysis of gated SPECT-MPI is a strong predictor of
MACE independent of other known predictors such as
perfusion defects or decreased LV ejection fraction.
INTRODUCTION
In Western countries, congestive heart failure is
a major cause of morbidity and mortality. Great
efforts have been made to search for optimised
treatment. The combination of cardiac resynchro-
nisation therapy (CRT) with standard pharmaco-
logical treatment is a widely used method for the
treatment of patients with moderate to severe
heart failure (New York Heart Association func-
tional class IIIeIV, reduced left ventricular ejection
fraction (LVEF) #35% and a broad QRS complex
>120 ms).1e3 It has been shown that left ventric-
ular (LV) dyssynchrony is a good predictor of
therapeutic response to CRT in those patients.4
Several non-invasive imaging methods, such as
tissue Doppler imaging, multigated blood pool
ventriculography acquisition (MUGA), MRI and
nuclear imaging, have been developed for the
accurate assessment of LV dyssynchrony. Among
these, MUGA has for long time represented the
most accurate and reproducible technique.5
Recently, phase analysis of gated single-photon
emission computed tomography myocardial
perfusion imaging (SPECT-MPI) using Fourier
harmonic function has been introduced as a reliable
alternative for LV dyssynchrony assessment.6 7
Although the pathophysiology of heart failure
has been well investigated and the outcome of
intra-left ventricular dyssynchrony has been docu-
mented in patients with heart failure,8 there is still
a lack of knowledge about the outcome value of
intra-left ventricular dyssynchrony assessed by
gated SPECT-MPI in an unselected population.
Hence, the purpose of this study was to assess the
prognostic value of LV dyssynchrony assessed from
phase analysis of SPECT-MPI as an independent
predictor of future cardiac events.
MATERIALS AND METHODS
The study included a total of 202 consecutive
patients who underwent a 1-day adenosine stress/
rest SPECT-MPI on a standard dual-detector SPECT
camera (Ventri, GE Healthcare, Milwaukee,
Wisconsin) for evaluation of known or suspected
coronary artery disease (CAD) andwhowere in sinus
rhythm during scanning. A weight-adjusted dose of
300e400 MBq 99mTc-tetrofosmin was injected at
stress, followed by a threefold higher dose at rest.
The latter (high dose) scan was used for phase anal-
ysis. The study protocol was approved by the insti-
tutional review board (local ethics committee of the
University Hospital Zurich) and written informed
consent was obtained from each patient.
Image acquisition and reconstruction
The SPECT-MPI acquisition was performed on
a Ventri dual-head camera with a low-energy, high-
resolution collimator, a 20% symmetric window at
140 keV, a 64364 matrix and an elliptic orbit with
step-and-shoot acquisition at 38 intervals over 1808
arc (458 right anterior oblique to 458 left posterior
oblique) with 30 steps (60 views). Scan time was set
to 25 s per frame for stress and rest, resulting in
a total acquisition time of 14 min 52 s (including
inter-step rotation time) for each scan as recom-
mended by the American Society of Nuclear Cardi-
ology.9 Images were reconstructed on a dedicated
workstation using a standard iterative reconstruc-
tion algorithm with ordered subset expectation
maximisation with two iterations and 10 subsets
into standard short as well as vertical and horizontal
long-axis and polar maps of perfusion encompassing
the entire left ventricle without using resolution
compensation or attenuation correction.
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Image interpretation
Image interpretation was visually performed in consensus by
two nuclear cardiologistsdboth of whom were blinded to the
clinical history and to the findings from phase analysisdon
short-axis, horizontal long-axis and vertical long-axis sections
and semiquantitative polar maps of perfusion as previously
reported.10 Reversible perfusion defect, fixed perfusion defect
and partially reversible defect were defined as abnormal perfu-
sion. Summed rest, stress and difference scores were calculated
based on a 20-segment model as previously reported.11 Ejection
fraction was determined from gated SPECT. An ejection fraction
<50% was defined as abnormal.12
Phase analysis
Phase analysis of Emory Cardiac Toolbox software6 (Emory
University/ Syntermed, Atlanta, Georgia, USA) was used to
evaluate the gated SPECT images obtained from Ventri. The
phase analysis technique measures the first Fourier harmonic
phase of regional LV count changes throughout the cardiac cycle,
which is approximately linear to the myocardial wall thickness
and therefore related to the time interval when a region in the
LV myocardial wall starts to contract. It provides information
on regularity of the distribution of these time intervals for the
entire left ventricledthat is, it is a measure of LV synchrony or
dyssynchrony (figure 1).4 6 7 13 The following two parameters
obtained from the phase analysis were evaluated, as they have
been shown to best identify LV dyssynchrony7 14: (1) phase
histogram bandwidth; (2) phase histogram standard deviation
(SD). The previously established normal values6 were
38.78611.88 (men) and 30.6869.68 (women) for histogram
bandwidth and 14.2865.18 (men) and 11.8865.28 (women) for
phase SD. LV dyssynchrony was defined as greater than the
mean + 2 standard deviations. LV dyssynchrony was considered
to be present if at least one of the parameters was above the cut-
off value. All analyses were performed by a reader who was
blinded to the history of the patient.
Long-term follow-up
Patient follow-up was accomplished by obtaining a structured
interview, and a clinical history assessed by a phone call to all
patients and/or general practitioners or cardiologists. Additional
information was gathered from medical charts and the registry
of government authorities in cases of death.
The median follow-up was 3.261.2 years. The date of the last
examination or consultation was used to determine follow-up.
The following major adverse cardiac events (MACE) were
defined as end points: cardiac death (as declared in the medical
charts) and hospitalisation for any cardiac reason, including
worsening of heart failure (as defined by the ESC guidelines),15
non-fatal myocardial infarction (as defined by the joint ESC/
ACCF/AHA/WHF consensus definition),16 unstable angina and
coronary revascularisation. All revascularisations during the first
Figure 1 Phase histograms of
a patient without (A) and a patient with
left ventricular dyssynchrony (B). In the
latter histogram bandwidth and SD are
enlarged.
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30 days were excluded because during this period any revascu-
larisation could potentially be directly triggered by the MPI test
result, which would introduce a confounder between diagnostic
and prognostic value.
Statistical analysis
SPSS software (SPSS 15.0, SPSS Inc) was used for statistical
testing. Quantitative variables were expressed as mean 6 stan-
dard deviation and categorical variables as frequencies or
percentages. Differences between the patient population with
and without LV dyssynchrony were tested for significance using
c2 tests for comparison of cross tables. For further comparison,
ManneWhitney U-tests were performed for age, body mass
index and LVEF. c2 Tests were used to determine differences in
gender, coronary risk factors and prevalence of known CAD.
Differences in survival over time were analysed by the
KaplaneMeier method. The log-rank test was used to compare
the survival curves. Univariate and multivariate Cox propor-
tional hazard regression models were used to identify indepen-
dent predictors of cardiac events. Variables were selected in
a stepwise forward selection manner; entry and retention sets
with p < 0.05 were considered to indicate a significant differ-
ence. Variables included in the models were age, male gender,
more than two risk factors (ie, hypertension, hyper-
cholesterolaemia, smoking, diabetes mellitus, a positive family
history of CAD), LV dyssynchrony, abnormal perfusion and
abnormal ejection fraction. A variable’s risk was expressed as
the hazard ratio with corresponding 95% confidence interval.
p Values of <0.05 were considered statistically significant.
RESULTS
In 202 patients phase analysis of Emory Cardiac Toolbox was
applied using rest MPI scans in order to assess LV dyssynchrony.
Follow-up was successful in 197 patients (97.5%). Baseline
characteristics of the study population are given in table 1. ECG
signs of ischaemic heart disease were present in 22 patients, of
whom 10 had LV dyssynchrony. QRS >120 ms was present in
15 patients, of whom six had LV dyssynchrony. All other
patients had normal ECG.
SPECT-MPI findings and phase analysis
Phase analysis disclosed LV dyssynchrony in 35 patients. Of
these, 31 patients had an abnormal histogram bandwidth and
26 patients an abnormal SD. In 22 patients both parameters
were abnormal. A total of 67 patients had an abnormal perfu-
sion; mean values for summed rest, stress and difference scores
were 3.965.6, 9.668.4 and 5.565.5, respectively. An abnormal
ejection fraction was found in 69 patients.
Outcome data
During 3.261.2 years of follow-up, 62 MACE occurred in
41 patients, including five cardiac deaths (table 2). The
KaplaneMeier survival curves revealed a significantly higher rate
of MACE (p<0.001) in patients with LV dyssynchrony than in
those without (figure 2). Similarly, patients with abnormal
perfusion and/or abnormal LVEF have a significantly higher rate
of MACE (p<0.001 and p<0.05). The predictive values of LV
dyssynchrony, abnormal perfusion and abnormal LVEF proved
to be significant by univariate Cox regression analysis (table 3).
In addition, there was a tendency for a higher annualised MACE
rate in those patients above versus those below the median value
of LV dyssynchrony (21.9% vs 16.6%), although this difference
fell short of statistical significance.
Moreover, by multivariate Cox regression analysis, three
independent predictors of MACE were identified: LV dyssyn-
chrony, the presence of more than two risk factors and abnormal
myocardial perfusion were independent predictors of MACE
(table 3).
DISCUSSION
Our results demonstrate an added prognostic value of LV
dyssynchrony assessed by SPECT-MPI over other known
predictors such as perfusion abnormalities and decreased LVEF. It
Table 1 Baseline characteristics of the study population (n¼197)
Event-free (n[156) With events (n[41) p Value
Characteristics
Male gender, n (%) 108 (69.2) 29 (70.7) NS
Age (years)
mean6SD, range 62611, 33e88 65610, 44e86 NS
Body mass index (kg/m2)
mean6SD, range 26.864.8, 18.7e50.0 28.265.0, 20.3e47.5 <0.05
Ejection fraction (%)
mean 6 SD, range 60.8612.0, 19e84 58.0612.4, 28e78 NS
Risk factors, n (%)
Hypertension 94 (60.3) 31 (75.6) NS
Dyslipidaemia 67 (42.9) 25 (61.0) <0.05
Diabetes 27 (17.3) 10 (24.4) NS
Smoking 45 (28.8) 20 (48.8) <0.05
Positive family history 40 (25.6) 17 (41.5) <0.05
Known CAD, n (%) 24 (15.4) 11 (26.8) NS
CAD, coronary artery disease.
Table 2 Major adverse cardiac events (MACE) in different groups
Patients without
LV dyssynchrony
(n[162)
Patients with
LV dyssynchrony
(n[35)
All patients
(n[197)
MACE
Cardiac death 4 1 5
Non-fatal myocardial infarction 5 2 7
Hospitalisation for any cardiac
reason
31 19 50
All MACE 40 22 62
LV, left ventricular.
Figure 2 Left ventricular (LV) dyssynchrony predicts major adverse
cardiac events (MACE).
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has been demonstrated earlier that ventricular dyssynchrony is
a predictor of poor outcome in patients with heart failure and in
patients with idiopathic dilated cardiomyopathy.8 17 To our
knowledge, our study is the first to show the prognostic value of
LV dyssynchrony assessed by phase analysis of gated SPECT in
an unselected population.
The results of this study are in line with other studies showing
that the presence of intra-LV dyssynchrony is an independent
predictor of MACE in patients with heart failure, extending these
findings to an unselected non-heart failure population.8 17 18
As heart failure has become one of the leading causes of
morbidity and mortality in Western countries, the role of diag-
nostic assessment and treatment of heart failure has gained
importance. So far, CRT in addition to medical treatment has
been used in patients with severe heart failure and a broad QRS
complex. Recently, focus has diverged to use CRT in patients
with less severe heart failure,19 20 suggesting that patients with
milder symptoms and evidence of LV dyssynchrony may benefit
from CRT implantation and achieve an improved quality of life,
exercise capacity, morbidity and mortality.
Our results confirm the importance of LV dyssynchrony
assessment for predicting long-term outcome. SPECT-MPI is
commonly part of the non-invasive management of patients
evaluated for potential CRT, and therefore obtaining reliable
dyssynchrony assessment from the same test confers an
important added value. The accuracy of LV dyssynchrony
assessment of SPECT-MPI has been previously validated,7 and
our outcome data confirm the clinical validity of this test.
Several studies have reported refinements of echocardio-
graphic measurements to assess myocardial dyssynchrony,
including Doppler interventricular delay calculated as the
difference between aortic and pulmonary pre-ejection delay,21
three-dimensional echocardiography,22 colour kinesis,23 or tissue
Doppler imaging.24 Although these methods may provide valu-
able information on the location and the degree of ventricular
dyssynchrony, no prognostic data are available. By contrast, our
data document the prognostic value of LV dyssynchrony as
assessed by phase analysis from gated SPECT.
LV dyssynchrony assessment with gated SPECT-MPI scans
has several potential advantages over other methods, such as the
averaged acquisition over several minutes minimising the impact
of respiratory or beat-to-beat variability and automated analysis,
both providing better reliability and repeatability than echocar-
diography as well as providing information on myocardial
perfusion at the same time. This may, at least in part, explain
why LV dyssynchrony assessed from gated SPECT confers
strong predictive outcome information. Although our study does
not offer mechanistic insights into the way in which dyssyn-
chrony translates into events, one could speculate that there is
inhomogeneous flow caused by premature atherosclerosis or
endothelial and microvascular dysfunction.
The relation between LV synchronicity and cardiovascular risk
factors has been documented earlier.25 26 It has been shown that
synchronicity was impaired in hypertensive patients and in
patients with metabolic syndromes. LV dyssynchrony may
therefore reflect a possible mechanistic link between cardiovas-
cular risk factors and cardiac events. As one of the most
common cause of chronic heart failure is CAD,27 a widely
available comprehensive diagnostic tool such as SPECT-MPI,
allowing assessment of both pathologiesdthat is, ischaemia and
dyssynchrony, at the same time, provides a great advantage.
We acknowledge the following limitations: first, the use of
a manual base and apex contour placement for phase analysis
may theoretically lead to arbitrary bias. However, the superiority
of manual placement over automated contour placement has
been previously proved.28 Second, the inclusion of revascular-
isation in the list of MACE may raise some criticism, because
any revascularisation may be triggered by the MPI finding
independent of LV dyssynchrony. However, to avoid this
confounder we excluded revascularisations within the first
30 days, as within this period revascularisations are typically
completed in our institution and interventions beyond this
point can be considered as independent events. Despite crossover
bias to revascularisation after MPI with ischaemia (probably
often linked with LV dyssynchrony, which may artificially
improve outcome in patients with dyssynchrony), LV dyssyn-
chrony remains a strong discriminating predictor. Finally, this
method provides exclusively data on LV intraventricular
dyssynchrony, while other methods (such as echocardiography29
or MUGA17) may provide data on right ventricular and
interventricular dyssynchrony. However, our data underline
the prognostic value of LV intraventricular dyssynchrony
assessment, in line with previous data showing that it is more
pertinent to find reliable assessment of intraventricular dyssyn-
chrony, while interventricular delay had no prognostic value.17
Therefore, intraventricular dyssynchrony has been suggested as
the best predictor of CRT response as measured by improved
outcome.17
In conclusion, this study documents that LV dyssynchrony
assessed by phase analysis of gated SPECT-MPI is a strong and
independent predictor of MACE.
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Table 3 Predictors of events at univariate and multivariate analysis (n ¼ 197)
Predictors Univariate HR (95% CI) p-value Multivariate HR (95% CI) p Value
Clinical characteristics
Age 1.033 (1.002 to 1.065) <0.05 1.029 (0.546 to 1.939) NS
Male gender 1.146 (0.584 to 2.247) NS 0.796 (0.392 to 1.618) NS
Cardiovascular risk factors
>2 Risk factors 2.172 (1.176 to 4.010) < 0.05 1.906 (1.023 to 3.548) <0.05
LV dyssynchrony 3.626 (1.932 to 6.803) < 0.001 2.049 (1.004 to 4.179) <0.05
Abnormal perfusion 3.895 (2.077 to 7.306) < 0.001 2.872 (1.416 to 5.826) <0.01
Abnormal LVEF 2.196 (1.190 to 4.053) < 0.05 1.315 (0.638 to 2.711) NS
CI, confidence interval; HR, hazard ratio; LVEF, left ventricular ejection fraction.
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